Our study does have limitations, including that we could not ascertain the effects of homozygous deletion of Gpr55 on seizure phenotypes of the Scn1a+/- mouse model of Dravet syndrome. The gene discussed is GPR55; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.